INDRAPRASTHA MEDICAL CORPORATION
|
INDRAPRASTHA MEDICAL CORPORATION Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 |
| CEPS(Rs) | 17.89 | 13.68 | 10.21 | 3.89 | 8.36 |
| DPS(Rs) | 4.50 | 3.00 | 2.50 | - | - |
| Book NAV/Share(Rs) | 52.12 | 41.39 | 35.50 | 29.75 | 29.21 |
| Tax Rate(%) | 25.37 | 26.48 | 25.86 | 45.69 | 9.48 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.53 | 13.72 | 12.87 | 6.57 | 10.40 |
| EBIT Margin(%) | 13.67 | 11.06 | 9.29 | 1.24 | 6.51 |
| Pre Tax Margin(%) | 13.35 | 10.67 | 8.90 | 0.70 | 5.80 |
| PAT Margin (%) | 9.96 | 7.84 | 6.60 | 0.38 | 5.25 |
| Cash Profit Margin (%) | 13.18 | 11.42 | 10.53 | 5.81 | 9.22 |
| Performance Ratios | |||||
| ROA(%) | 19.39 | 16.94 | 13.12 | 0.53 | 10.01 |
| ROE(%) | 28.92 | 24.44 | 19.60 | 0.86 | 17.05 |
| ROCE(%) | 39.70 | 34.46 | 27.58 | 2.80 | 20.15 |
| Asset Turnover(x) | 1.95 | 2.16 | 1.99 | 1.39 | 1.91 |
| Sales/Fixed Asset(x) | 2.34 | 2.27 | 1.92 | 1.36 | 1.97 |
| Working Capital/Sales(x) | 8.73 | 11.76 | 13.89 | 24.03 | 444.97 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.43 | 0.44 | 0.52 | 0.74 | 0.51 |
| Receivable days | 18.57 | 18.54 | 22.75 | 43.60 | 34.13 |
| Inventory Days | 2.34 | 3.06 | 3.85 | 6.19 | 4.48 |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 12.70 | 8.27 | 9.14 | 211.45 | 7.13 |
| PCE(x) | 9.60 | 5.68 | 5.73 | 13.82 | 4.06 |
| Price/Book(x) | 3.30 | 1.88 | 1.65 | 1.81 | 1.16 |
| Yield(%) | 2.62 | 3.86 | 4.28 | - | - |
| EV/Net Sales(x) | 1.08 | 0.53 | 0.53 | 0.76 | 0.35 |
| EV/Core EBITDA(x) | 6.42 | 3.63 | 3.98 | 11.36 | 3.34 |
| EV/EBIT(x) | 7.93 | 4.81 | 5.67 | 60.97 | 5.38 |
| EV/CE(x) | 2.83 | 1.54 | 1.01 | 1.08 | 0.65 |
| M Cap / Sales | 1.26 | 0.65 | 0.60 | 0.80 | 0.37 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.29 | 23.70 | 44.80 | -26.17 | 5.40 |
| Core EBITDA Growth(%) | 30.81 | 36.88 | 186.74 | -52.97 | 7.18 |
| EBIT Growth(%) | 40.10 | 47.26 | 981.00 | -85.90 | 5.08 |
| PAT Growth(%) | 43.89 | 46.96 | 2,415.88 | -94.66 | 53.54 |
| EPS Growth(%) | 43.89 | 46.96 | 2,415.62 | -94.66 | 53.54 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.01 |
| Current Ratio(x) | 1.86 | 1.72 | 1.68 | 1.22 | 1.01 |
| Quick Ratio(x) | 1.82 | 1.66 | 1.58 | 1.14 | 0.93 |
| Interest Cover(x) | 41.91 | 28.38 | 24.19 | 2.28 | 9.14 |
| Total Debt/Mcap(x) | - | - | - | - | 0.01 |
Compare Financial Ratios of peers of INDRAPRASTHA MEDICAL CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAPRASTHA MEDICAL CORPORATION | ₹3,820.7 Cr | -10.3% | -9.2% | 123.4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹98,602.5 Cr | -7.6% | -3.9% | 33% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹97,801.4 Cr | -6.8% | 3.5% | 73.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹48,253.1 Cr | -0.4% | 0.3% | 79.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,764.1 Cr | -4.6% | -3% | 17.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹26,088.7 Cr | -0.8% | -0.8% | 19.5% | Stock Analytics | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | -10.3% |
-9.2% |
123.4% |
| SENSEX | -2.5% |
-5.2% |
19.5% |
You may also like the below Video Courses
